Sodium-dependent dopamine transporter
| GO Term | Evidence Code | Reference |
|---|---|---|
| chloride transport |
|
|
| amino acid transport | ||
| amine transport | ||
| norepinephrine transport |
|
|
| sodium ion transmembrane transport |
| GO Term | Evidence Code | Reference |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| axon | ||
| axolemma |
| GO Term | Evidence Code | Reference |
|---|---|---|
| chloride channel activity |
|
|
| amine transmembrane transporter activity | ||
| dopamine:sodium symporter activity | ||
| dopamine:sodium symporter activity | ||
| metal ion binding |
|
|
| Pathway Name | Organism |
|---|---|
| SLC-mediated transport of neurotransmitters | Caenorhabditis elegans |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0090145 | dopamine beta-hydroxylase deficiency |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026